Pluristyx Partnership (iPSC-MSC Banks)
Regenerative Medicine
DevelopmentActive
Key Facts
About Stemmatters
Stemmatters is a private, revenue-generating CDMO based in Guimarães, Portugal, offering end-to-end contract development and cGMP manufacturing solutions for regenerative medicine products. It operates as a one-stop shop, providing services in contract development, analytical testing, formulation development, and manufacturing for cell therapies, including iPSC-derived products and CAR-T cells. The company is actively engaged in collaborative R&D projects and partnerships, positioning itself as a key European player in the advanced therapy CDMO landscape.
View full company profileOther Regenerative Medicine Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Regenerative Medicine Program(s) | Cell BioEngines | Pre-clinical |
| Rational Protocol Design for Cell Therapy | Cellular Intelligence | Research/Pre-clinical |
| Accelerated Biosciences Collaboration (Trophoblast iPSC) | Stemmatters | Development |
| Undisclosed Program | CRISPR Therapeutics | Preclinical |